Alphatec (ATEC) Surges 5.19% Amidst Strong Buy Ratings

Author's Avatar
Nov 07, 2024

Alphatec Holdings Inc. (ATEC, Financial) stock experienced a significant price surge of 5.19%, reaching $9.33 per share. The trading volume hit 928,012 shares, with a turnover rate of 0.65% and a price fluctuation of 6.88% within the session.

The company's latest earnings report indicates revenue of $151 million, a net loss of $39.62 million, with an earnings per share (EPS) of -$0.28. The gross profit stood at $82.08 million, and the price-to-earnings (P/E) ratio was -7.37.

In terms of stock ratings, 92% of the 12 investment firms covering Alphatec have issued a buy recommendation, while 8% suggest holding, with no sell recommendations.

Within the broader medical device industry, the sector experienced an overall decline of 0.54%. Notable gainers among related stocks include Outset Medical, Inc., Myomo, Inc., and Lensar, Inc. Active stocks in the sector were Bluejay Diagnostics, Inc., Autonomix Medical, Inc., and Tenon Medical, Inc., with turnover rates of 203.18%, 24.10%, and 18.73% respectively. Stocks with significant price swings include Spectral Ai Inc C/Wts (To Pur Com), Outset Medical, Inc., and Bluejay Diagnostics, Inc., with price fluctuations of 34.74%, 32.90%, and 28.84% respectively.

Alphatec Holdings Inc is a medical technology company specializing in spinal surgery products to address spine-related diseases and conditions. Their technologies include cervical posterior fixation, anterior cervical discectomy and fusion, lateral interbody fusion, and posterior lumbar interbody fusion methods.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.